[18F]-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer

被引：0
|
作者：
Ehab M. Kamel
Matthias T. Wyss
Mathias K. Fehr
Gustav K. von Schulthess
Gerhard W. Goerres
机构：
[1] University Hospital of Zurich,Division of Nuclear Medicine, Department of Medical Radiology
[2] University Hospital of Zurich,Department of Gynecology and Obstetrics
来源：
Journal of Cancer Research and Clinical Oncology | 2003年 / 129卷
关键词：
Breast cancer; FDG-PET; Recurrence; Tumor marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 153
页数：6
相关论文
共 50 条
  • [21] [18F]-fluorodeoxyglucose positron emission tomography in an animal model of mania
    Hougland, Matthew Tyler
    Gao, YongLin
    Herman, Laura
    Ng, Chin K.
    Lei, Zhenmin
    El-Mallakh, Rif S.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 65S - 65S
  • [22] Predicting Outcome in Patients with Rhabdomyosarcoma: Role of [18F] Fluorodeoxyglucose Positron Emission Tomography
    Casey, Dana L.
    Wexler, Leonard H.
    Fox, Josef J.
    Dharmarajan, Kavita V.
    Schoder, Heiko
    Price, Alison N.
    Wolden, Suzanne L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (05): : 1136 - 1142
  • [23] Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients
    Bastiaannet, E
    Oyen, WJG
    Meijer, S
    Hoekstra, OS
    Wobbes, T
    Jager, PL
    Hoekstra, HJ
    BRITISH JOURNAL OF SURGERY, 2006, 93 (02) : 243 - 249
  • [24] Sequential positron emission tomography using [18F] fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer
    Couturier, Olivier
    Jerusalem, Guy
    N'Guyen, Jean-Michel
    Hustinx, Roland
    CLINICAL CANCER RESEARCH, 2006, 12 (21) : 6437 - 6443
  • [25] Sensitivity of [18F]-Fluorodeoxyglucose-Positron Emission Tomography in Patients With Active Myelopathy
    Ayrignac, Xavier
    Orgeval, Jessica
    Mariano-Goulart, Denis
    MAYO CLINIC PROCEEDINGS, 2014, 89 (06) : 859 - 859
  • [26] Detection of distant metastases in breast cancer patients: Comparison between [18F]-fluorodeoxyglucose positron emission tomography and conventional imaging
    Mahner, S.
    Schirrmacher, S.
    Mueller, V.
    Habermann, C.
    Brenner, W.
    Schwarz, J. Dose
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] 18fluorodeoxyglucose positron emission tomography in the management of patients with suspected pancreatic cancer
    Rose, DM
    Delbeke, D
    Beauchamp, RD
    Chapman, WC
    Sandler, MP
    Sharp, KW
    Richards, WO
    Wright, JK
    Frexes, ME
    Pinson, CW
    Leach, SD
    ANNALS OF SURGERY, 1999, 229 (05) : 729 - 738
  • [28] Role of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence in patients with cervical cancer
    Bhoil, Amit
    Mittal, Bhagwant Rai
    Bhattacharya, Anish
    Santhosh, Sampath
    Patel, Firuza
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2013, 28 (04): : 216 - 220
  • [29] Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer
    De Giorgi, Ugo
    Valero, Vicente
    Rohren, Eric
    Dawood, Shaheenah
    Ueno, Naoto T.
    Miller, M. Craig
    Doyle, Gerald V.
    Jackson, Summer
    Andreopoulou, Eleni
    Handy, Beverly C.
    Reuben, James M.
    Fritsche, Herbert A.
    Macapinlac, Homer A.
    Hortobagyi, Gabriel N.
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) : 3303 - 3311
  • [30] FDG (18 fluorodeoxyglucose) : Positron emission tomography and breast cancer
    Menkès, MCJ
    Milhaud, MG
    Paolaggi, MJB
    de Gennes, MJL
    Picard, MJD
    Boulu, MR
    Nordmann, MR
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2005, 189 (05): : 975 - 978
12345